dehydroevodiamine has been researched along with scopolamine hydrobromide in 3 studies
| Studies (dehydroevodiamine) | Trials (dehydroevodiamine) | Recent Studies (post-2010) (dehydroevodiamine) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
|---|---|---|---|---|---|
| 48 | 1 | 18 | 7,548 | 563 | 1,401 |
| Protein | Taxonomy | dehydroevodiamine (IC50) | scopolamine hydrobromide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, W; Kang, SS; Kim, JS; Kim, SH; Lee, YJ; Park, CH; Suh, YH | 1 |
| Choi, SH; Jeong, SJ; Kim, HS; Kim, SS; Lee, SH; Lee, YJ; Park, CH; Suh, YH | 1 |
| Chen, CF; Chou, CJ; Liao, JF; Wang, HH | 1 |
3 other study(ies) available for dehydroevodiamine and scopolamine hydrobromide
| Article | Year |
|---|---|
Novel anticholinesterase and antiamnesic activities of dehydroevodiamine, a constituent of Evodia rutaecarpa.
Topics: Acetylcholinesterase; Alkaloids; Amnesia; Animals; Male; Memory; Plant Extracts; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Scopolamine | 1996 |
Dehydroevodiamine.HCl prevents impairment of learning and memory and neuronal loss in rat models of cognitive disturbance.
Topics: Alkaloids; Amnesia; Animals; Avoidance Learning; Cell Death; Cerebral Infarction; Cholinesterase Inhibitors; Cognition Disorders; Entorhinal Cortex; Hippocampus; Learning; Maze Learning; Memory; Muscarinic Antagonists; Neurons; Rats; Rats, Sprague-Dawley; Reaction Time; Scopolamine | 2000 |
Dehydroevodiamine attenuates beta-amyloid peptide-induced amnesia in mice.
Topics: Alkaloids; Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Avoidance Learning; Cholinesterase Inhibitors; Male; Mice; Mice, Inbred ICR; Muscarinic Antagonists; Peptide Fragments; Physostigmine; Scopolamine | 2001 |